Table 1.
Comparison of LD, PD, and %PD/LD in the study groups.
| Group | LD | PD | PD/LD% | |||
|---|---|---|---|---|---|---|
| Median | IQR | Median | IQR | Median | IQR | |
| 1 (n = 15) | 174.00 | 34.25 | 78.00 | 11.43 | 44.83AB | 4.10 |
| 2 (n = 14) | 182.48 | 47.93 | 70.40 | 12.76 | 37.82A | 8.67 |
| 3 (n = 14) | 303.76 | 28.96 | 232.12 | 16.11 | 75.74C | 8.20 |
| 4 (n = 13) | 307.33 | 15.33 | 191.33 | 14.66 | 61.80CD | 1.24 |
| 5 (n = 13) | 331.10 | 7.00 | 192 | 9.00 | 58.02BD | 1.27 |
| 6 (n = 14) | 181.53 | 4.2 | 0 | 0 | 0E | 0 |
LD Lesion depth, PD Sealant/infiltrant penetration depth, %PD/LD Percentage of PD to LD, IQR interquartile range. Values with the same superscript capital letter were not significantly different. Statistical significance: p < 0.05.
Group 1: Phosphoric acid + Clinpro™; group 2: Phosphoric acid + Aegis®; group 3: Icon®; group 4: Hydrochloric acid + Clinpro™; group 5: Hydrochloric acid + Aegis®; group 6: Control.